Skip to main content
. 2021 Oct 22;12:768741. doi: 10.3389/fimmu.2021.768741

Table 1.

The subgroup analyses of the association between infections and the risk of AS.

Subgroups No. of items OR/RR/HR (95% CI) I 2 (%) Chi-square test P-value
Case-control studies
Comorbidities 0.139
 Adjusted 2 1.26 (0.94–1.70) 95.7
 Unadjusted 8 1.66 (1.35–2.03) 45.8
Infection Type 0.864
 Bacterial 4 1.31 (0.61–2.78) 55.3
 Other* 6 1.40 (1.15–1.70) 82.7
Infection Site 0.347
 Immune system 2 1.46 (1.42–1.49) 0.0
 Other** 10 1.27 (0.96–1.69) 86.7
Cohort studies
Comorbidities 0.157
 Adjusted 6 1.39 (1.15–1.68) 71.6
 Unadjusted 1 0.86 (0.45–1.63) 0.0
Infection Type 0.766
 Bacterial 2 0.70 (0.10–4.78) 87.4
 Viral 4 1.43 (1.22–1.66) 35.3
 Other* 3 1.44 (1.12–1.86) 74.0
Infection Site 0.863
 Immune system 2 1.27 (0.61–2.65) 66.0
 Other** 5 1.36 (1.11–1.67) 76.6

AS, ankylosing spondylitis; CI, confidence interval; HR, hazard ratio; OR, odds ratio, RR, relative risk.

*Other types of infection include fungi, chlamydia, and mycoplasma.

**Other sites of infection include the digestive system, respiratory system, and genitourinary system.